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Summary Data are limited on seizure recurrence after antiepileptic drug (AED)
discontinuation in operated seizure-free patients. We reviewed seizure outcome in
patients who came off AEDs after being seizure-free for 2 years following temporal
lobe surgery in our center. Thirty-nine (68%) of 57 patients who discontinued AED
therapy remained seizure-free. They had a younger age at surgery than the group with
seizure recurrence ( p = 0.01). Earlier surgery may be a favorable predictor for seizure
freedom after AED discontinuation.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Surgical outcome after temporal lobectomy has
been extensively investigated, but not in relation
to seizure freedom off antiepileptic drugs (AEDs). In
the most widely used outcome classification (Engel
Classification),1 class I (excellent) outcome includes
patients with persistent non-disabling auras and
patients with atypical seizures in conjunction with
AED withdrawal. Little is known about seizure-free
rates with AED withdrawal, and predictors of suc-
cessful AED discontinuation. Yet, one important goal* Corresponding author at: Vanderbilt University, Department
of Neurology, 2311 Pierce Ave, Room 2224, Nashville, TN 37232,
USA. Tel.: +1 615 936 2591; fax: +1 615 936 0223.
E-mail address: bassel.abou-khalil@vanderbilt.edu
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doi:10.1016/j.seizure.2006.10.007of many patients is to discontinue seizure medica-
tions. Patients who become seizure-free off AEDs
can potentially be considered cured. We reviewed
our series of patients who underwent temporal
resections for epilepsy to identify those who were
able to successfully discontinue antiepileptic drugs.
We also investigated factors that may predict ability
to stop AEDs successfully.2Methods
We reviewed our epilepsy surgery database for all
patients who underwent surgery for temporal lobe
epilepsy. These included all patients operated
between 1988 and 1999. Our institutional protocol
is to consider medication withdrawal after 2 years of
seizure freedom postoperatively, if the patient is. Published by Elsevier Ltd. All rights reserved.
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Table 1 Surgical outcome at 2 years and at last
follow-up
Classification At 2 years Al last follow-up
beyond 2 years
Class I





Class II 24 (17%) 13 (10%)
Class III 12 (8%) 9 (7%)







from I to II, III, or IV
6
Outcome upgraded from II to I 14
Outcome upgraded from III or IV to I 4
Lost to follow-up after 2 years 9willing to accept some risk of seizure recurrence.
Medications were tapered gradually over at least 1—
2 months (but taper could be considerably slower).
In patients taking more than one AED, one AED is
tapered and completely removed before the taper
of the other AED is initiated.
We identified patients who came off AEDs after
being seizure-free for at least 2 years and reviewed
seizure outcome after AED withdrawal. We analyzed
age at seizure onset, duration of epilepsy before
surgery, type of surgery, side of surgery, age at
surgery, epilepsy risk factors, and nature of the
epileptogenic lesion on MRI. The follow-up data
were collected from medical records and we also
attempted to contact patients by phone when fol-
low-up data weremissing. We entered all the data in
a computerized database. Patients with successful
AED withdrawal and those with recurrent seizures
were compared for factors described above using
either t-test for continuous variables or Chi-square
for categorical variables. The procedures were
approved by the Vanderbilt Institutional Review
Board.4 were class I
2 were class II
3 were class III
a All percentages were based on patients with known follow-
up status, excluding deaths unrelated to epilepsy. Denomi-
nator at 2 years: 145; at last FU: 135.
b Causes of death: SUDEP: 1; possible SUDEP: 1; unrelated
cause: 1; accidental death unrelated to epilepsy: 1 (>2 years
after surgery).Results
Surgery and surgical outcome
During the study period (between 1988 and 1999),
150 patients had temporal lobe epilepsy surgery, 66
on the left and 84 on the right. Two patients had
repeat surgery (one left and one right), for a total of
152 resective procedures. One hundred and twenty-
four patients had standard tailored temporal lobec-
tomies. The rest had more limited resections
(extension of previous lobectomy, 2 patients; amyg-
dalohippocampectomy, 12; amygdalohippocam-
pectomy after lateral resection, 1; lesionectomy,
10; lesionectomy and partial lobectomy, 1; lesio-
nectomy and amygdalohippocampectomy, 2). At
last follow-up (mean 6 years), 105 patients had class
I seizure outcome (Table 1).
AED discontinuation
Fifty-seven patients discontinued AED therapy and
had follow-up data. The minimum duration of fol-
low-up after AED discontinuation was 1 year. Thirty-
nine (68%) of the 57 patients had no seizure recur-
rence after discontinuation. The successful group
had a younger age at surgery than the group with
seizure recurrence (Table 2). This was statistically
significant (two-tailed t-test, p < 0.01). No other
significant differences were found in the parameters
examined (Table 2). Two patients who successfullydiscontinued AEDs had continued to have seizures in
the initial postoperative period (they were classified
Engel II and III), but later became seizure-free for
2 years. One patient who had a seizure recurrence
was in Engel class II during the early postoperative
period. All other patients were in class I outcome
throughout their postoperative course on AEDs.
Forty-three patients with class I outcome at 2
years did not come off AEDs. The main reason was
persistence of auras or evidence of residual seizure
tendency (such as occurrence of atypical seizure
with missing medication doses). Eight patients with
class IA outcome did not come off AEDs. The main
reason was follow-up by another physician who
did not suggest the option of AED withdrawal (4
patients). Two of these had benign tumors and were
followed by a neuro-oncologist. Three patients did
not want to take the risk of seizure recurrence. Two
of these were also using AEDS for other reasons
(neuropathic pain andmood control). The remaining
patient with musicogenic epilepsy had an occipital
lesion that may have accounted for rare visual
seizures. She had a temporal lobectomy which
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Table 2 Characteristics of patient groups with no seizure recurrence and with seizure recurrence after AED
discontinuation
Seizure recurrence 18 (32%) No seizure recurrence 39 (68%) p
Gender (F/M) 9/9 24/14 N.S.
Age at onset (years) 16.7 11.8 N.S.
Epilepsy duration (years) 22.5 18.2 N.S.
Type of surgery Lobectomy-14 Lobectomy-34 N.S.
Sel AH-2 Sel AH-2
Lesionectomy-2 Lesionectomy-3
Side of surgery (L/R) 6/12 18/21 N.S.
Age at surgery (years) 39.2 30 0.01a
Febrile seizures (Y/N) 7/11 14/25 N.S.
Family History (Y/N) 5/13 13/24 N.S.
Head trauma (Y/N) 5/13 7/31 N.S.
Foreign tissue Lesion (Y/N) 4/13 8/31 N.S.
MTS (Y/N) 12/6 25/14 N.S.
F, female; M, male; L, left; R, right; Y, yes; N, no; N.S., not significant, Sel AH, selective amygdalohippocampectomy; MTS, mesial
temporal sclerosis.
a Two-tailed t-test.eliminated her habitual complex partial seizures,
but as the occipital lesion was not removed, AEDS
were not stopped due to the risk of visual seizure
recurrence.
Outcome after seizure recurrence
Among the 18 patients who had seizure recurrence,
14 became seizure-free again after AED reinstitu-
tion, and 2 have developed refractory epilepsy.
Their ages at surgery were 56 and 42. The remaining
two patients have chosen to stay off AEDs despite
recurrence of seizures, because their recurrent sei-
zures were mild and they disliked the adverse
effects of AEDs.Discussion
The main finding of this study is that approximately
two-thirds of patients who came off AEDS after 2
years without seizures remained seizure-free. This
percentage is similar to published reports in
adults,3,4 but less than in one series in children.5
This difference between adults and children is con-
sistent with our second important finding, that
patients who remained seizure-free after AED dis-
continuation had a lower mean age at surgery than
patients who had seizure recurrence. This relation-
ship between age at surgery and successful AED
discontinuation is supported by other studies,
including one study of long-term outcome that did
not specifically analyze AED discontinuation.3,6 In
our study, the duration of epilepsy was not statisti-
cally different for the groups with and withoutseizure recurrence, even though the mean duration
of epilepsy tended to be longer for the group with
seizure recurrence after AEDwithdrawal (Table 2). A
possible contributing factor is that the age at onset
also tended to be later in that group. One study in
patients with mesial temporal sclerosis and another
that included all operated patients found that the
duration of epilepsy was a predictor of long-term
outcome.7,8
Other studies did not find a relationship between
age at surgery and long-term outcome.9,10 It is
possible that seizure freedom on AEDs and contin-
ued seizure freedom after AED withdrawal have
different predictors. This would not be surprising,
as seizure freedom on AEDs could just reflect that
epilepsy has become responsive to pharmacother-
apy, while continued seizure freedom after AED
withdrawal may indicate cure from epilepsy.
We found no difference in the underlying pathol-
ogy between the groups with and without seizure
recurrence after AED discontinuation. The two main
categories of mesial temporal sclerosis and foreign
tissue lesions were equally represented in both
groups of patients. Mesial temporal sclerosis was
the most common pathology, present in 67% of
patients with and 64% without seizure recurrence.
Foreign tissue lesions were present in 24% of those
with recurrence and 21% of those without. Similarly,
the surgical approach was not a factor. Thus, it
appears that for patients who are seizure-free after
surgery, the above factors are not important in the
prediction of seizure freedom after AED withdrawal.
The majority of patients with seizure relapse
after AED discontinuation became seizure-free
again. Two patients (14%) developed refractory
98 M. Al-Kaylani et al.epilepsy. Refractory epilepsy may develop after
AED withdrawal in up to 23% of general epilepsy
patients who were previously seizure-free.11 The
percentage again seems to be smaller in pediatric
patients.12 It is not clear if the refractory epilepsy is
related to AED withdrawal, or whether it was going
to develop anyway, independent of AED changes. In
one study, there was no difference between AED
withdrawal and AED continuation groups with
respect to the risk of relapse, suggesting that
relapse was not causally related to AED withdra-
wal.13 This issue cannot be resolved properly with-
out a prospective controlled study.
The possible development of refractory epilepsy
could be the most potent argument against AED
withdrawal following epilepsy surgery. Until this
question is clarified, it is wise to counsel our
patients that if seizures recur following AED with-
drawal they could be difficult to control in some
patients. Nevertheless, new progress in pharma-
cotherapy may improve outcome in patients whose
relapsing seizures appear medication resistant.14,15References
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